Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer

被引:9
|
作者
Cheng, Hou-Hsuan [1 ,2 ]
Lin, Jen-Kou [1 ,3 ]
Chen, Wei-Shone [1 ,3 ]
Jiang, Jeng-Kai [1 ,3 ]
Yang, Shung-Haur [1 ,3 ]
Chang, Shih-Ching [1 ,3 ,4 ]
机构
[1] Taipei Vet Gen Hosp, Div Colon & Rectal Surg, Dept Surg, Taipei, Taiwan
[2] Taichung Vet Gen Hosp, Div Colon & Rectal Surg, Dept Surg, Taichung, Taiwan
[3] Natl Yang Ming Univ, Dept Surg, Fac Med, Sch Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan
关键词
BRAF mutation; Colorectal cancer; Stage IV; Survival; Metastatic pattern; III COLON-CANCER; BRAF V600E MUTATION; MICROSATELLITE INSTABILITY; STAGE-II; CARCINOEMBRYONIC ANTIGEN; ADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTOR; LYNCH SYNDROME; POOR SURVIVAL; KRAS;
D O I
10.1007/s00384-018-3095-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To investigate the clinicopathological features and prognostic significance of the BRAFV600E mutation in Asian patients with colorectal cancer. We retrospectively reviewed the medical records of 1969 patients with colorectal cancer admitted to Taipei Veterans General Hospital for surgical treatment between 2000 and 2013. The measured endpoint was overall survival after surgery. The prognostic value of the BRAFV600E mutation was analyzed using the log-rank test and Cox regression analysis. The BRAFV600E mutation was detected in 106 (5.4%) patients and associated with female gender, abnormal cancer antigen (CA)19-9 at diagnosis, microsatellite status, right-sided primary tumors, mucinous histology, poor differentiation, and lymphovascular invasion. Metastatic patterns were more common in non-regional lymph node metastasis (20.8 vs. 7.4%, p = 0.06) and peritoneal seeding (41. vs. 21.2%, p = 0.04). Mutations were not prognostic in the overall survival of the entire study group but only in specific patients: age < 65, normal carcinoembryonic antigen at diagnosis, and stage IV disease. The BRAFV600E mutation was associated with distinct clinicopathological features and metastatic patterns. The overall survival rate was lower in selected colorectal patients with the BRAFV600E mutation.
引用
收藏
页码:1173 / 1181
页数:9
相关论文
共 50 条
  • [1] Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer
    Hou-Hsuan Cheng
    Jen-Kou Lin
    Wei-Shone Chen
    Jeng-Kai Jiang
    Shung-Haur Yang
    Shih-Ching Chang
    [J]. International Journal of Colorectal Disease, 2018, 33 : 1173 - 1181
  • [2] Prevalence of BRAFV600E mutation in Asian patients with thyroid cancer
    Bychkov, Andrey
    [J]. MALAYSIAN JOURNAL OF PATHOLOGY, 2017, 39 (01) : 95 - 96
  • [3] Prevalence of BRAFV600E mutation in Asian patients with thyroid cancer RESPONSE
    Navarro-Locsin, Cecilia Gretchen
    [J]. MALAYSIAN JOURNAL OF PATHOLOGY, 2017, 39 (01) : 97 - 97
  • [4] PROTEOMIC ANALYSIS OF COLORECTAL CANCER WITH BRAFV600E MUTATION
    Zhou, Biting
    Xu, Kailun
    Shao, Yingkuan
    Zheng, Xi
    Zheng, Shu
    [J]. GUT, 2020, 69 : A34 - A35
  • [5] Clinicopathological Significance of BRAFV600E Mutation in Colorectal Cancer: An Updated Meta-Analysis
    Wang, Jianhua
    Shen, Jiajia
    Huang, Chi
    Cao, Meng
    Shen, Lizong
    [J]. JOURNAL OF CANCER, 2019, 10 (10): : 2332 - 2341
  • [6] BRAFV600E mutation promoted the growth and chemoresistance of colorectal cancer
    Ma, Zenghui
    Qi, Zhenguang
    Gu, Chaofeng
    Yang, Zhou
    Ding, Yue
    Zhou, Yichan
    Wang, Wei
    Zou, Qi
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (04): : 1486 - 1497
  • [7] Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanoma
    Tang, Huan
    Kong, Yan
    Si, Lu
    Cui, Chuanliang
    Sheng, Xinan
    Chi, Zhihong
    Dai, Jie
    Yu, Sifan
    Ma, Meng
    Wu, Xiaowen
    Yu, Jiayi
    Xu, Tianxiao
    Yu, Huan
    Yan, Junya
    Guo, Jun
    [J]. ONCOLOGY LETTERS, 2018, 15 (02) : 1839 - 1844
  • [8] BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer
    Ilie, Marius I.
    Long-Mira, Elodie
    Hofman, Veronique
    Mouroux, Jerome
    Vignaud, Jean-Michel
    Gauchotte, Guillaume
    Begueret, Hugues
    Merlio, Jean-Philippe
    Emile, Jean-Francois
    Hebuterne, Xavier
    Hofman, Paul
    [J]. PATHOLOGY, 2014, 46 (04) : 311 - 315
  • [9] Clinical significance of BRAFV600E and TERT promoter mutation in papillary thyroid microcarcinoma
    Jincai Xue
    Qinjiang Liu
    Youxin Tian
    Xiaofeng Hou
    [J]. Oncology and Translational Medicine, 2019, 5 (02) : 75 - 79
  • [10] Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy
    Zhu, Guoquan
    Deng, Yuying
    Pan, Liqin
    Ouyang, Wei
    Feng, Huijuan
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Chen, Yanying
    Luo, Jiaxin
    [J]. ENDOCRINE CONNECTIONS, 2019, 8 (06) : 754 - 763